advanced non-small cell lung cancer can change everything. but your first treatment could be a chemo-free combination of two immunotherapies that works differently. it could mean a chance to live longer. opdivo plus yervoy is for adults newly diagnosed with non-small cell lung cancer that has spread and that tests positive for pd-l1 and does not have an abnormal egfr or alk gene. opdivo plus yervoy is the first and only fda-approved combination of two immunotherapies opdivo plus yervoy equals... a chance for more starry nights. more sparkly days. more big notes. more small treasures. more family dinners. more private desserts.